Holen Sie sich die Stockscreener-App
1.78
2.73%
-0.05
Handel nachbörslich:
1.88
0.10
+5.62%
Schlusskurs vom Vortag:
$1.83
Offen:
$1.84
24-Stunden-Volumen:
1.25M
Relative Volume:
1.80
Marktkapitalisierung:
$197.62M
Einnahmen:
$21.05M
Nettoeinkommen (Verlust:
$-142.93M
KGV:
-1.281
EPS:
-1.3895
Netto-Cashflow:
$-184.07M
1W Leistung:
+17.88%
1M Leistung:
-7.77%
6M Leistung:
-9.18%
1J Leistung:
+21.92%
1-Tages-Spanne:
$1.74
$2.00
1-Wochen-Bereich:
$1.455
$2.035
52-Wochen-Spanne:
$1.09
$3.3999
Alector Inc Stock (ALEC) Company Profile
Firmenname
Alector Inc
Sektor
Branche
Telefon
415-231-5660
Adresse
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO
Compare ALEC vs VRTX, REGN, ARGX, RVMD, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ALEC
Alector Inc
|
1.78 | 167.65M | 21.05M | -142.93M | -184.07M | -1.3895 |
VRTX
Vertex Pharmaceuticals Inc
|
496.07 | 121.57B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
784.36 | 69.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
865.04 | 55.61B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
205.15 | 39.98B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
348.27 | 33.81B | 5.76B | 514.49M | 1.10B | 4.4813 |
Alector Inc Stock (ALEC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-15 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2026-03-10 | Hochstufung | BTIG Research | Neutral → Buy |
| 2025-10-22 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-10-22 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2025-10-22 | Herabstufung | Mizuho | Outperform → Neutral |
| 2025-10-22 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-10-22 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2025-07-28 | Hochstufung | Mizuho | Neutral → Outperform |
| 2024-12-17 | Herabstufung | Mizuho | Outperform → Neutral |
| 2024-12-16 | Herabstufung | Stifel | Buy → Hold |
| 2024-12-04 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-11-29 | Bestätigt | H.C. Wainwright | Buy |
| 2024-11-26 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2023-12-14 | Hochstufung | Stifel | Hold → Buy |
| 2023-12-12 | Eingeleitet | Deutsche Bank | Buy |
| 2023-09-25 | Eingeleitet | Goldman | Sell |
| 2023-09-22 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-01-06 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-09-09 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-07-07 | Eingeleitet | Mizuho | Buy |
| 2022-04-13 | Eingeleitet | Goldman | Sell |
| 2022-03-08 | Herabstufung | Stifel | Buy → Hold |
| 2021-09-27 | Eingeleitet | William Blair | Outperform |
| 2021-01-15 | Fortgesetzt | BofA Securities | Buy |
| 2020-06-24 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-04-28 | Eingeleitet | Goldman | Buy |
| 2020-03-06 | Eingeleitet | Citigroup | Buy |
| 2020-02-27 | Eingeleitet | Barclays | Overweight |
| 2020-02-19 | Eingeleitet | Stifel | Buy |
| 2019-11-21 | Eingeleitet | BTIG Research | Buy |
| 2019-03-04 | Eingeleitet | Barclays | Overweight |
| 2019-03-04 | Eingeleitet | BofA/Merrill | Buy |
| 2019-03-04 | Eingeleitet | Morgan Stanley | Overweight |
| 2019-03-04 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Alector Inc Aktie (ALEC) Neueste Nachrichten
Alector Inc (ALEC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Alector Inc (ALEC) Institutional Confidence - TradingKey
Alector Inc (ALEC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Alector Inc (ALEC) Balance Sheet - TradingKey
Alector Inc (ALEC) Cash Flow - TradingKey
Alector Inc (ALEC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
ALEC|Alector Inc|Price:1.480|Chg%:-0.010 - TradingKey
TradingKey - TradingKey
Alector Inc (ALEC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
ALEC|Alector Inc|Price:1.520|Chg%:+0.040 - TradingKey
Spruce Street Capital LP Buys 983,082 Shares of Alector, Inc. $ALEC - MarketBeat
Alector, Inc. Revenue Breakdown – NASDAQ:ALEC - TradingView
Alector Inc (ALEC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Alector (ALEC) Goldman Sachs 45th Annual Global Healthcare Conference Summary - Quartr
Alector (ALEC) Proxy filing Summary - Quartr
Alector Q1 2026 Earnings: Narrower Loss Surprises, Yet Shares Dip Amid Revenue AbsenceCapex Guidance - DonanımHaber
GSK Adds Positive Phase 3 Lung Cancer Data, Ends Alector Partnership - Sahm
GSK exits Alector neurodegeneration alliance after trial failures - The Pharma Letter
Form 4 Alector Inc For: 9 July By Investing.com - Investing.com Nigeria
Alector (ALEC) awards 20,000 RSUs to principal accounting officer - Stock Titan
GSK ends brain drug alliance with Alector - BioPharma Dive
GSK Bids Farewell To Alector Dementia Deal - insights.citeline.com
GSK Walks Away From AlectorPipeline Reset Story Begins (NASDAQ:ALEC) - Seeking Alpha
GSK Terminates Neuroscience Collaboration with Alector Following Drug Trial SetbacksEPS Surprise History - dars.gov.et
Alector stock plummets 13% as GSK terminates neuroscience pact (GSK:NYSE) - Seeking Alpha
Alector (ALEC) Shares Drop 13% Following Termination of GSK Coll - GuruFocus
Alector and GSK partnership to end after dementia, Alzheimer’s drug failures - whbl.com
Alector, Inc. Terminates Material Definitive Agreement – Key 8-K Filing Update July 2026 - Minichart
Alector and GSK partnership to end after dementia, Alzheimer's drug failures - Reuters
Alector Ends GSK Collaboration, Retires Hercules Capital Debt - TipRanks
Alector to End GSK Progranulin Collaboration; Repays $10.4 Million Hercules Loan - TradingView
Alector (ALEC) sees GSK end antibody collaboration while repaying $10.4M loan - Stock Titan
ALEC Q1 2026 Earnings: Narrowing Losses with 39.95% EPS Beat; Stock Rises 2.49%Investor Earnings Call - dars.gov.et
Alector Inc. (ALEC) Recovers From Support as Shares Edge HigherValue Area Low - DonanımHaber
ALEC Q1 2026 Earnings: Smaller-than-Expected Loss Drives Positive SentimentEarnings Surprise Stocks - dars.gov.et
0Z2 Forecast — Price Target — Prediction for 2027 - TradingView
Alector, Inc. Actuals & Estimates (NASDAQ:ALEC) - TradingView
ALEC Forecast — Price Target — Prediction for 2027 - TradingView
Alector (ALEC) Surges 11.45% as Shares Test Key Resistance at $2.1Buy Signal Reports - dars.gov.et
A2PCBM Forecast — Price Target — Prediction for 2027 - TradingView
Price to book forward of Alector, Inc. – GETTEX:0Z2 - TradingView
Price to sales forward of Alector, Inc. – NASDAQ:ALEC - TradingView
Enterprise value to revenue forward of Alector, Inc. – NASDAQ:ALEC - TradingView
Price to sales forward of Alector, Inc. – GETTEX:0Z2 - TradingView
Price to book forward of Alector, Inc. – NASDAQ:ALEC - TradingView
Enterprise value to EBITDA forward of Alector, Inc. – GETTEX:0Z2 - TradingView
Enterprise value to EBIT forward of Alector, Inc. – NASDAQ:ALEC - TradingView
Alector Inc. (ALEC) Q1 2026 Earnings: EPS Beat on Narrower Loss, No Revenue YetEarnings Season Outlook - dars.gov.et
Alector Inc. (ALEC) Edges Higher as Stock Approaches Key ResistanceCall Wall - dars.gov.et
ALEC Q1 2026 Earnings: Better-than-Expected Loss Narrowing Drives Double-Digit Stock SurgeEstimate Accuracy - dars.gov.et
ALEC Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Double-Digit RallyGeographic Revenue Trends - dars.gov.et
Finanzdaten der Alector Inc-Aktie (ALEC)
Umsatz
Nettogewinn
Free Cashflow
ENV
Alector Inc-Aktie (ALEC) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Wong-Sarad Grace | Principal Accounting Officer |
Jun 02 '26 |
Sale |
1.97 |
5,709 |
11,271 |
98,936 |
| Wong-Sarad Grace | Principal Accounting Officer |
Jun 03 '26 |
Sale |
1.88 |
3,475 |
6,543 |
95,461 |
| Berkley Neil Lindsay | CFO & Chief Business Officer |
Jun 02 '26 |
Sale |
1.97 |
19,360 |
38,221 |
379,900 |
1.84%
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):